These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16514678)

  • 1. Effect of medium sugar source on the production of retroviral vectors for gene therapy.
    Coroadinha AS; Ribeiro J; Roldão A; Cruz PE; Alves PM; Merten OW; Carrondo MJ
    Biotechnol Bioeng; 2006 May; 94(1):24-36. PubMed ID: 16514678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of osmotic pressure on the production of retroviral vectors: Enhancement in vector stability.
    Coroadinha AS; Silva AC; Pires E; Coelho A; Alves PM; Carrondo MJ
    Biotechnol Bioeng; 2006 Jun; 94(2):322-9. PubMed ID: 16528756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrovirus producer cell line metabolism: implications on viral productivity.
    Coroadinha AS; Alves PM; Santos SS; Cruz PE; Merten OW; Carrondo MJ
    Appl Microbiol Biotechnol; 2006 Oct; 72(6):1125-35. PubMed ID: 16598449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
    Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
    Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral vector production under serum deprivation: The role of lipids.
    Rodrigues AF; Carmo M; Alves PM; Coroadinha AS
    Biotechnol Bioeng; 2009 Dec; 104(6):1171-81. PubMed ID: 19655394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State-of-the-art of the production of retroviral vectors.
    Merten OW
    J Gene Med; 2004 Feb; 6 Suppl 1():S105-24. PubMed ID: 14978755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of retroviral vectors for gene therapy with the human packaging cell line FLYRD18.
    Gerin PA; Searle PF; Al-Rubeai M
    Biotechnol Prog; 1999; 15(5):941-8. PubMed ID: 10514266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving retroviral vectors production: role of carbon sources in lipid biosynthesis.
    Amaral AI; Coroadinha AS; Merten OW; Alves PM
    J Biotechnol; 2008 Nov; 138(3-4):57-66. PubMed ID: 18793684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
    Tolmachov O
    Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of retroviral production from packaging cell lines expressing the human immunodeficiency type 1 VPU gene.
    Kobinger GP; Mouland AJ; Lalonde JP; Forget J; Cohen EA
    Gene Ther; 1997 Aug; 4(8):868-74. PubMed ID: 9338017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
    Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF
    Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of culture parameters on the production of retroviral vectors by a human packaging cell line.
    McTaggart S; Al-Rubeai M
    Biotechnol Prog; 2000; 16(5):859-65. PubMed ID: 11027182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of new retroviral producer cells from adenoviral and retroviral vectors.
    Lin X
    Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses.
    Torrent C; Jullien C; Klatzmann D; Perricaudet M; Yeh P
    Cancer Gene Ther; 2000 Aug; 7(8):1135-44. PubMed ID: 10975674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
    Ghani K; Cottin S; Kamen A; Caruso M
    Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors.
    Schucht R; Coroadinha AS; Zanta-Boussif MA; Verhoeyen E; Carrondo MJ; Hauser H; Wirth D
    Mol Ther; 2006 Aug; 14(2):285-92. PubMed ID: 16697259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized conditions for the production of recombinant amphotropic retroviral vector preparations.
    Kaptein LC; Greijer AE; Valerio D; van Beusechem VW
    Gene Ther; 1997 Feb; 4(2):172-6. PubMed ID: 9081708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human suspension culture packaging cell line for production of high-titre retroviral vectors.
    Chan LM; Coutelle C; Themis M
    Gene Ther; 2001 May; 8(9):697-703. PubMed ID: 11406764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From retroviral vector production to gene transfer: spontaneous inactivation is caused by loss of reverse transcription capacity.
    Carmo M; Panet A; Carrondo MJ; Alves PM; Cruz PE
    J Gene Med; 2008 Apr; 10(4):383-91. PubMed ID: 18240154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
    Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
    Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.